Revenue: The sum of all revenue fields included for a company's operating activities.
Capstone Therapeutics Corp. (CAPS) had Revenue of $44.88M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$44.88M |
$-5.50M |
|
$35.31M |
|
$9.57M |
|
$45.51M |
|
$-0.64M |
|
$-1.48M |
|
$-2.12M |
|
$-2.12M |
|
$-2.56M |
|
$-2.56M |
|
$-2.56M |
|
$-2.56M |
|
$-0.64M |
|
$-0.12M |
|
0.16M |
|
0.16M |
|
$-34.87 |
|
$-34.87 |
|
| Balance Sheet Financials | |
$12.80M |
|
$1.59M |
|
$34.42M |
|
$47.22M |
|
$12.55M |
|
$6.32M |
|
$37.73M |
|
$50.28M |
|
$-3.06M |
|
$-26.39M |
|
$-3.06M |
|
0.16M |
|
| Cash Flow Statement Financials | |
$3.82M |
|
$-0.12M |
|
$-3.74M |
|
$0.05M |
|
$0.01M |
|
$-0.04M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.02 |
|
-- |
|
-- |
|
1.94 |
|
-4.72 |
|
21.33% |
|
-1.42% |
|
-1.42% |
|
-0.27% |
|
-4.73% |
|
-12.24% |
|
$3.70M |
|
-- |
|
-- |
|
-- |
|
0.95 |
|
3.66 |
|
16.25 |
|
22.46 |
|
83.81% |
|
9.71% |
|
-5.43% |
|
-78.50% |
|
$-19.40 |
|
$23.48 |
|
$24.24 |
|